Literature DB >> 1757348

Nebulized vs. instilled exogenous surfactant in an adult lung injury model.

J Lewis1, M Ikegami, R Higuchi, A Jobe, D Absolom.   

Abstract

Three days after subcutaneous injection of N-nitroso-N-methylurethane (NNNMU) to induce lung injury, adult rabbits were mechanically ventilated and lung function was evaluated. Each animal then received either nebulized Survanta (Neb Surv), nebulized saline (Neb Saline), nebulized gas alone (Neb Gas), or tracheally instilled Survanta (Inst Surv). The ventilation efficiency index (VEI) value increased significantly compared with pretreatment values (P less than 0.01) over a 3-h treatment period for the Neb Surv animals, whereas VEI values for the other three groups decreased after treatment (P less than 0.05). Arterial PO2-to-fraction of inspired O2 ratios and dynamic compliance values significantly decreased after treatment for the Inst Surv group (P less than 0.05). Pressure-volume curves demonstrated a significantly greater volume at maximal pressure for the Neb Surv group compared with each of the other groups studied (P less than 0.01). The calculated quantity of surfactant recovered in lung tissue for the Neb Surv group was only 4.9 +/- 1.0 mg lipid/kg compared with 100 mg lipid/kg delivered to the Inst Surv group. Surfactant administered as an aerosol resulted in modest physiological improvements in this model of lung injury and was superior to the tracheal instillation technique.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757348     DOI: 10.1152/jappl.1991.71.4.1270

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  Nebulisation of surfactants in an animal model of neonatal respiratory distress.

Authors:  T F Fok; M al-Essa; M Dolovich; F Rasid; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

2.  Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.

Authors:  Ilaria Milesi; David G Tingay; Emanuela Zannin; Federico Bianco; Paolo Tagliabue; Fabio Mosca; Anna Lavizzari; Maria Luisa Ventura; C Elroy Zonneveld; Elizabeth J Perkins; Don Black; Magdy Sourial; Raffaele L Dellacá
Journal:  Pediatr Res       Date:  2016-03-08       Impact factor: 3.756

Review 3.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

4.  Synthetic liposomes are protective from bleomycin-induced lung toxicity.

Authors:  William M Gwinn; Mayanga C Kapita; Ping M Wang; Mark F Cesta; William J Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-20       Impact factor: 5.464

5.  Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.

Authors:  Amy Z Stetten; Steven V Iasella; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  Curr Opin Colloid Interface Sci       Date:  2018-01-13       Impact factor: 6.448

6.  Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Authors:  Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Thorsten Colaris; Bhola Dahal; Dieter Walmrath; Heinz Harbach; Jochen Wilhelm; Werner Seeger; Reinhold Schmidt; Andreas Guenther
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

Review 7.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.

Authors:  T K Huang; C F T Uyehara; V Balaraman; C Y Miyasato; D Person; E Egan; D Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

Review 9.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

10.  Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats.

Authors:  Yu Sun; Rui Yang; Ji-gen Zhong; Feng Fang; Jin-jin Jiang; Ming-yao Liu; Jian Lu
Journal:  Crit Care       Date:  2009-03-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.